By continuing to use the site you agree to our Privacy & Cookies policy

Your browser seems to have cookies disabled. For the best experience of this website, please enable cookies in your browser.


Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.


Drug combination for cardiology patients approved

The European Medicines Agency has approved the oral antiplatelet drug ticagrelor (Brilique) for use in combination with aspirin.

Combining the two drugs has been found to aid in the prevention of atherothrombotic events in adult patients who have had a myocardial infarction or an episode of unstable angina.

This includes patients managed medically and those managed with percutaneous coronary intervention or coronary artery bypass grafting.

Have your say

You must sign in to make a comment.

Related Jobs

Sign in to see the latest jobs relevant to you!